标题 |
A 28-week, multi-center randomized, double-blind, placebo-controlled study to evaluate the potential of Dapagliflozin plus Exenatide in combination with high-dose intensive insulin therapy compared to Placebo in obese insulin-resistant patients with
一项为期28周、多中心、随机、双盲、安慰剂对照研究,旨在评估达格列嗪联合艾塞那肽联合高剂量强化胰岛素治疗与安慰剂治疗肥胖胰岛素抵抗患者的潜力
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |